GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

T2 Biosystems TTOO · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.01

+4900.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

T2 Biosystems — daily TTOO Delayed
Market value
$280,500
Last close × shares
Volume
631
Shares, 9 Nov 2026

About T2 Biosystems

Its shares trade under the ticker TTOO. It has been listed since 7 August 2014. In the fiscal year to 31 December 2023, it reported revenue of $7.2m and a net loss of $50.1m. At that date it held total assets of $34.8m and shareholders' equity of −$28.0m.

T2 Biosystems, Inc. engages in the development of proprietary technology platform. The company is headquartered in Lexington, Massachusetts. The company went IPO on 2014-08-07. The firm's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL). The firm's initial development efforts target sepsis, hemostasis and Lyme disease. T2MR is a miniaturized, magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. Its platform detects a range of targets, including molecular targets, such as deoxyribonucleic acid (DNA), immunodiagnostics, such as proteins, and a range of hemostasis measurements. The firm offers T2Dx Instrument (T2Dx) and the T2Candida Panel.

Figures and description from our data supplier, not checked against the company's own report.

More about T2 Biosystems →

How it makes its money

Revenue, year to 31 Dec 2021

  • Product [Member] $16.6m · 59.3%
  • Product, consumables. $14.5m · 51.7%
  • Contribution. $11.4m · 40.7%
  • Contribution revenue. $11.4m · 40.7%

Latest on T2 Biosystems

Our reporting

We have not reported on T2 Biosystems yet.

Next results

13 Nov 2026

Due on 13 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is T2 Biosystems's ticker?

T2 Biosystems trades as TTOO on its US listing, under ISIN US89853L3024.

What was T2 Biosystems's last closing price?

0.01 on 9 Nov 2026. The figure is in USD and is never converted.

When does T2 Biosystems next report results?

Results are expected on 13 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.